Dyne Therapeutics (DYN) Non-cash Items (2019 - 2026)
Dyne Therapeutics (DYN) recorded quarterly Non-cash Items of $4.0 million in Q1 2026, down 92.47% quarter-over-quarter from $52.8 million in Q4 2025, and up 2.62% on a YoY basis from $3.9 million in Q1 2025.
Dyne Therapeutics (DYN) Non-cash Items (2019 - 2026) Analysis & Trends
Dyne Therapeutics' Non-cash Items history runs 8 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Non-cash Items rose 2.62% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 2.62% YoY), while the FY2025 annual figure was $3.6 million, up 4.87% from the prior year.
- Non-cash Items was $4.0 million for Q1 2026 at Dyne Therapeutics, down from $52.8 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $178.0 million in Q2 2024 to a low of $3.5 million in Q2 2025.
- Historically, Non-cash Items has averaged $35.7 million across 5 years, with a median of $14.5 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Non-cash Items jumped 3070.08% in 2022, then slumped 98.03% in 2025.
- A 5-year view of Non-cash Items shows it stood at $34.9 million in 2022, then gained by 11.05% to $38.7 million in 2023, then soared by 57.55% to $61.0 million in 2024, then retreated by 13.5% to $52.8 million in 2025, then tumbled by 92.47% to $4.0 million in 2026.
- The last three Non-cash Items figures came in at $4.0 million (Q1 2026), $52.8 million (Q4 2025), and $14.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.97 Mn |
| Mar 31, 2026 | 3.97 Mn |
| Dec 31, 2025 | 52.78 Mn |
| Dec 31, 2025 | 52.78 Mn |
| Sep 30, 2025 | 14.50 Mn |
| Sep 30, 2025 | 14.50 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 61.02 Mn |
| Dec 31, 2024 | 61.02 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 178.02 Mn |
| Jun 30, 2024 | 178.02 Mn |
| Mar 31, 2024 | 133.49 Mn |
| Mar 31, 2024 | 133.49 Mn |
| Dec 31, 2023 | 38.73 Mn |
| Dec 31, 2023 | 38.73 Mn |